--- title: "Restructuring and M&A Shape Trajectories for Braskem, Conagra and Arogo Capital" type: "News" locale: "en" url: "https://longbridge.com/en/news/295518630.md" description: "Led by Braskem's debt mediation and Conagra's dividend adjustment, a diverse group of ten companies across biopharma, consumer staples, and logistics are accelerating capital optimization and strategic overhauls in the second half of 2026." datetime: "2026-08-11T10:13:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295518630.md) - [en](https://longbridge.com/en/news/295518630.md) - [zh-HK](https://longbridge.com/zh-HK/news/295518630.md) --- # Restructuring and M&A Shape Trajectories for Braskem, Conagra and Arogo Capital Companies spanning petrochemicals, consumer goods, and specialized finance are executing critical debt restructurings and cross-border mergers in the second half of 2026, according to recent corporate filings and regulatory disclosures. ### Braskem (BAK.US) Braskem's shares have continued to underperform the broader market as the petrochemical producer navigates severe liquidity constraints. The company secured a **60-day** stay of execution from a São Paulo judicial restructuring court in late **July 2026**, creating a window to mediate its **USD 3.7 billion** debt load, according to people familiar with the matter. Braskem reported recurring EBITDA of **1 billion reais** in the first quarter, and management is evaluating long-term capital structure alternatives amid a sustained slump in global polymer demand. ### Conagra Brands (CAG.US) The packaged food manufacturer has seen its stock rally in recent weeks, outpacing several peers in the consumer staples sector following a major dividend adjustment. Conagra Brands reported a **3.6%** increase in net sales for the fiscal fourth quarter of 2026, alongside an adjusted EPS of **USD 0.47**. The company's mid-July decision to halve its annualized dividend from **USD 1.40** to **USD 0.70** per share was widely received by institutional investors as a pragmatic move to deleverage. The firm is forecasting an adjusted operating margin of **10.0% to 10.5%** for fiscal 2027. ### NewAmsterdam Pharma (NAMS.US) The late-stage clinical biopharmaceutical firm is advancing its commercialization pipeline despite widening quarterly deficits. NewAmsterdam reported a second-quarter net loss of **USD 64.1 million** in early **August 2026**, an expansion of **269%** year-over-year, though it retains a robust cash position of **USD 678.3 million**. The company is actively preparing for the rollout of its lead cardiovascular asset, obicetrapib, which received a positive opinion from a European Medicines Agency committee in late July. ### Arogo Capital Acquisition (ACOG.US) The special purpose acquisition company is accelerating its transition into the smart mobility sector. Following a Nasdaq delisting warning in mid-2024, Arogo Capital Acquisition struck a definitive business combination agreement in early **2025** with Bangkok Tellink, a Thailand-based telecom and IoT solutions provider. The transaction is valued at **USD 350 million**, and executives expect the merger to close later this year, shifting the combined entity's focus toward sustainable transportation technologies. ### Nuveen Enhanced Municipal Value Fund (NVVE.US) In the tax-exempt fixed income space, the Nuveen Enhanced Municipal Value Fund is maintaining stable asset levels amid shifting macroeconomic expectations. As of **August 2026**, the closed-end fund oversees approximately **USD 1.91 billion** in assets under management with a price-to-book ratio holding at **4.29**. Portfolio managers are continuing to utilize leverage to invest in long-term, investment-grade municipal bonds to secure consistent income streams for shareholders. ### Funko (FNKO.US) The pop culture consumer products maker is working to streamline its operational footprint amidst uneven retail spending patterns. Funko relies heavily on its licensed collectible figures and accessories to drive volume, and internal efforts are currently focused on clearing excess inventory. Management is prioritizing high-margin intellectual property partnerships to repair profitability metrics heading into the holiday season. ### AMN Healthcare Services (AMN.US) As a dominant player in healthcare staffing, AMN Healthcare Services is adapting to normalized hospital budgets following the pandemic-era boom. The company is leaning on its technology-driven workforce solutions to help hospital networks control surging temporary labor costs. Analysts note that the adoption rate of AMN's digital platforms will serve as a crucial leading indicator for its revenue growth trajectory in the upcoming quarters. ### Aegon (AEG.US) The multinational life insurance and pensions group is continuing to execute its multi-year capital optimization strategy. Aegon is aggressively divesting non-core peripheral assets to free up liquidity and concentrate on high-growth segments. According to people familiar with the firm's strategic planning, executives are prioritizing cash generation and strengthening asset management operations across mature Western markets. ### Under Armour (UA.US) Under Armour is attempting to reinvigorate its brand presence amid fierce competition from both legacy athletic giants and emerging activewear challengers. The company is reallocating capital expenditures toward performance footwear innovation while simultaneously restructuring its global wholesale distribution networks. Management expects these structural shifts to gradually improve inventory turnover rates and margin profiles. ### CAI International (CAI.US) Since its multi-billion dollar acquisition by Mitsubishi HC Capital in **2021**, the transport asset leasing firm has been deeply integrated into its parent company's global logistics infrastructure. Amid fluctuations in global shipping rates and container demand in **2026**, CAI International continues to leverage its extensive intermodal fleet to supply vital leasing capacity to major international shipping lines. Overall, institutional fund flow data indicates that investors are increasingly rewarding companies with definitive restructuring timelines and clean balance sheets, while highly leveraged operators face mounting pressure to execute turnarounds. _This article does not constitute investment advice._ ### Related Stocks - [FNKO.US](https://longbridge.com/en/quote/FNKO.US.md) - [ACOG.US](https://longbridge.com/en/quote/ACOG.US.md) - [AMN.US](https://longbridge.com/en/quote/AMN.US.md) - [NVVE.US](https://longbridge.com/en/quote/NVVE.US.md) - [BAK.US](https://longbridge.com/en/quote/BAK.US.md) - [AEG.US](https://longbridge.com/en/quote/AEG.US.md) - [NAMS.US](https://longbridge.com/en/quote/NAMS.US.md) - [CAG.US](https://longbridge.com/en/quote/CAG.US.md) - [CAI.US](https://longbridge.com/en/quote/CAI.US.md) - [UA.US](https://longbridge.com/en/quote/UA.US.md) ## Related News & Research - [Conagra Brands (CAG) Is Back In The Spotlight, What Is Driving Attention?](https://longbridge.com/en/news/296000366.md) - [Aegon boosts second-half buyback after capital generation beats forecasts](https://longbridge.com/en/news/296444217.md) - [45,236 Shares in AMN Healthcare Services Inc $AMN Acquired by Assenagon Asset Management S.A.](https://longbridge.com/en/news/295994171.md) - [Quantinno Capital Management LP Has $1.01 Million Stock Position in AMN Healthcare Services Inc $AMN](https://longbridge.com/en/news/296018037.md) - [Nuvve GAAP EPS of -$14.45, revenue of $1.23M](https://longbridge.com/en/news/296071033.md)